The FAVOR II China Study

CompletedOBSERVATIONAL
Enrollment

308

Participants

Timeline

Start Date

June 13, 2017

Primary Completion Date

July 20, 2017

Study Completion Date

July 20, 2017

Conditions
Coronary Artery DiseaseMyocardial IschemiaCardiovascular DiseasesArteriosclerosisCoronary DiseaseArterial Occlusive DiseasesHeart DiseasesVascular Diseases
Interventions
DIAGNOSTIC_TEST

Fractional Flow Reserve (FFR)

FFR measured by pressure wire, QFR computed by coronary angiographic images

Trial Locations (5)

Unknown

Fuwai Hospital, Beijing

Chinese PLA General Hospital, Beijing

Peking University Third Hospital, Beijing

Guangdong General Hospital, Guangzhou

Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
collaborator

Pulse Medical Imaging Technology (Shanghai) Co., Ltd

INDUSTRY

lead

China National Center for Cardiovascular Diseases

OTHER_GOV

NCT03191708 - The FAVOR II China Study | Biotech Hunter | Biotech Hunter